| ²é¿´: 466 | »Ø¸´: 1 | |||
yulaiguangгæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÓйØÇ¿Öƽµ½âµÄ·¨¹æÎļþºÍÏà¹ØÎÄÏ× ÒÑÓÐ1È˲ÎÓë
|
| ÇóÖúÓйØÇ¿Öƽµ½âµÄ·¨¹æÎļþºÍÏà¹ØÎÄÏ× |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸085502£¬267·ÖÇóµ÷¼Á
ÒѾÓÐ16È˻ظ´
085801µçÆø×¨Ë¶272Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
366Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á
ÒѾÓÐ37È˻ظ´
279ѧ˶ʳƷרҵÇóµ÷¼ÁԺУ
ÒѾÓÐ18È˻ظ´
290µ÷¼ÁÉúÎï0860
ÒѾÓÐ31È˻ظ´
Ò»Ö¾Ô¸085802 323·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
277Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
322Çóµ÷¼Á£¬08¹¤¿Æ
ÒѾÓÐ4È˻ظ´
²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð
ÒѾÓÐ30È˻ظ´
zongyuan
¾èÖú¹ó±ö (ÖªÃû×÷¼Ò)
- Ó¦Öú: 304 (´óѧÉú)
- ½ð±Ò: 4637.7
- É¢½ð: 2225
- ºì»¨: 61
- Ìû×Ó: 8282
- ÔÚÏß: 823Сʱ
- ³æºÅ: 766948
- ×¢²á: 2009-05-10
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
| FDA Perspectives Scientific Considerations of Forced Degradation Studies in ANDA Submissions |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : FDA_Perspectives_Scientific_Considerations_of_Forced_Degradation_Studies_in_ANDA_Submissions.pdf
2016-03-31 16:05:49, 521.26 K
2Â¥2016-03-31 16:05:49













»Ø¸´´ËÂ¥